The latest data in our current survey highlights geographical differences in the comorbidities experienced by people with diabetes along with satisfaction with their glucose control.
Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.
dQ&A data show that users' perceptions of an algorithm's aggressiveness strongly impact satisfaction and NPS.
